American Society of Hirudotherapy

Leech Therapy Following Digital Replantation and Revascularization

Research article published in The Journal of hand surgery (2020)

Last Updated: June 18, 2026Reviewed by: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Narrative reviewClinical TrialsPickrell B et al. · The Journal of hand surgery, 2020

Abstract

Venous congestion after digital replantation or revascularization threatens digit survival in the immediate postoperative period. External bloodletting, including leech therapy, provides a central role in salvage of the congested finger. Although there have been previous studies describing the initiation of leech therapy for digits experiencing venous insufficiency, few published articles and no consensus guidelines have discussed the weaning of leeches in the postoperative period. We review the current evidence behind leech therapy and offer a treatment algorithm based on available data and existing leech weaning protocols.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal ArticleReview
Indexed MeSH termsAmputation, TraumaticAnimalsFingersHumansLeechesLeechingReplantation

Summary

Venous congestion after digital replantation or revascularization threatens digit survival in the immediate postoperative period. External bloodletting, including leech therapy, provides a central role in salvage of the congested finger.

Why This Matters for Hirudotherapy

This review examines leech therapy as a means of managing venous congestion after digital replantation or revascularization, with particular attention to the postoperative weaning of leeches, an area the authors note has few published discussions and no consensus guidelines. It summarizes available evidence and proposes a treatment algorithm derived from existing data and leech weaning protocols. The work is directly relevant to hirudotherapy practice, as it addresses a well-established clinical indication for medicinal leech application and highlights a practical management gap — namely, how and when to discontinue therapy once venous outflow improves. As a review, it does not generate new primary clinical data; the abstract does not specify the number, design, or quality of the underlying studies supporting the algorithm, nor does it report outcome metrics validating the proposed protocol, so its recommendations should be understood as a synthesis of available evidence rather than tested guidance.

Citation

Leech Therapy Following Digital Replantation and Revascularization.

Pickrell B et al. · The Journal of hand surgery, 2020

Added to ASH library: March 18, 2026 · Site last updated: June 18, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.